Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SS
#3277
Rank
NZ$8.32 B
Marketcap
NZ$5.12
Share price
-0.05%
Change (1 day)
-20.85%
Change (1 year)

Earnings for Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SS)

Earnings in 2026 (TTM): NZ$1.17 Billion

According to Guangzhou Baiyunshan Pharmaceutical Holdings's latest financial reports the company's current earnings are NZ$11.47 Billion. In 2024 the company made an earning of NZ$0.84 Billion a decrease over its 2023 earnings that were of NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guangzhou Baiyunshan Pharmaceutical Holdings from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.17 B
2024 NZ$0.84 B-30.8%
2023 NZ$1.22 B-4.38%
2022 NZ$1.27 B4.32%
2021 NZ$1.22 B35.17%
2020 NZ$0.90 B-10.54%
2019 NZ$1.01 B-1.38%
2018 NZ$1.02 B64.22%
2017 NZ$0.62 B27.61%
2016 NZ$0.48 B12.59%
2015 NZ$0.43 B9.34%
2014 NZ$0.39 B6.26%
2013 NZ$0.37 B162.26%
2012 NZ$0.14 B63.15%
2011 NZ$87.51 M9.1%
2010 NZ$80.21 M40.76%
2009 NZ$56.98 M9.3%
2008 NZ$52.13 M-50.94%
2007 NZ$0.10 B32.74%
2006 NZ$80.05 M26.99%
2005 NZ$63.04 M84.93%
2004 NZ$34.08 M-41.1%
2003 NZ$57.88 M-0.86%
2002 NZ$58.38 M